2020
DOI: 10.1097/ccm.0000000000004637
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Driving Pressure Change During Extracorporeal Membrane Oxygenation in Adults With Acute Respiratory Distress Syndrome: A Randomized Crossover Physiologic Study*

Abstract: Objectives: Venovenous extracorporeal membrane oxygenation is an effective intervention to improve gas exchange in patients with severe acute respiratory distress syndrome. However, the mortality of patients with severe acute respiratory distress syndrome supported with venovenous extracorporeal membrane oxygenation remains high, and this may be due in part to a lack of standardized mechanical ventilation strategies aimed at further minimizing ventilator-induced lung injury. We tested whether a con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
39
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(41 citation statements)
references
References 28 publications
1
39
0
1
Order By: Relevance
“… 15 A recent randomised crossover physiological study in 10 patients with ARDS on ECMO confirmed those results, showing that even 10 cm H 2 O of driving pressure applied during ultra-protective ventilation may increase biotrauma, compared with a strategy with zero driving pressure. 3 However, differences observed in the present study cannot be explained by differences in driving pressure or mechanical power, as these variables were comparable between the three study groups and within ranges usually considered as safe. A possible explanation is that driving pressure and mechanical power reflect the global mechanical burden of mechanical ventilation, but they may not reflect the presence of VILI at the regional level.…”
Section: Discussionsupporting
confidence: 41%
See 1 more Smart Citation
“… 15 A recent randomised crossover physiological study in 10 patients with ARDS on ECMO confirmed those results, showing that even 10 cm H 2 O of driving pressure applied during ultra-protective ventilation may increase biotrauma, compared with a strategy with zero driving pressure. 3 However, differences observed in the present study cannot be explained by differences in driving pressure or mechanical power, as these variables were comparable between the three study groups and within ranges usually considered as safe. A possible explanation is that driving pressure and mechanical power reflect the global mechanical burden of mechanical ventilation, but they may not reflect the presence of VILI at the regional level.…”
Section: Discussionsupporting
confidence: 41%
“…Studies have shown that further limiting V T and driving pressures in patients with ARDS with the use of ECMO may be beneficial. 1 , 2 , 3 …”
mentioning
confidence: 99%
“…In the SOC cohort, VV ECMO allowed an ultraprotective mechanical ventilation strategy with tidal volumes well below 6 mL/kg of ideal body weight ( 22 24 ). PEEP and overall respiratory system compliance remained unchanged during the first 5 days after the intervention (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, definitive data are still missing on the use of an ultraprotective lung ventilation strategy during VV ECMO, compared with standard ARDSnet tidal volume calculations. However, recently, Del Sorbo et al ( 24 ) demonstrated that there was a linear relationship between tidal volume and plasma biomarkers of ventilator-induced lung injury, whereas Costa et al ( 37 ) found that among ventilator variables, only driving pressure and respiratory rate had significant associations with mortality.…”
Section: Discussionmentioning
confidence: 99%
“…However, a time-dependent analysis showed that higher tidal volume and lower driving pressure (both suggesting resolution of pulmonary mechanics and function) was associated with survival. More recently, it has been shown that even on ECMO there are reductions in surrogate systemic biomarkers of VALI when the ventilation strategy is modified ( Sorbo et al, 2020 ). Sorbo et al showed linear reductions in the plasma concentrations of interleukin(IL)-6, soluble receptor for advanced glycation end products, IL-1ra, tumor necrosis factor alpha, surfactant protein D, and IL-10 with changes in driving pressure on ECMO.…”
Section: Clinical Managementmentioning
confidence: 99%